Approval · Notice of Compliance 5573 · 1994
BEZALIP: Notice of Compliance 5573
Issued March 28, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5573
- Date
- March 28, 1994
- Company
- Boehringer Mannheim (Canada) LteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
Medicinal ingredients
- BEZAFIBRATE 200 MG per TAB
- BEZAFIBRATE 400 MG per TAB